Activation of the Keap1/Nrf2 Pathway as an Adaptive Response to an Electrophilic Metabolite of Morphine
Biological and Pharmaceutical Bulletin · 2023
DOI: 10.1248/bpb.b22-00543 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2023. Verfasst von Kohei Matsuo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Science, Fukuoka University. Hauptthemen laut MEDLINE: Glutamate-Cysteine Ligase, NF-E2-Related Factor 2. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmaceutical Science, Fukuoka University.
- Faculty of Medicine, University of Tsukuba.
- Graduate School of Biomedical Sciences, Nagasaki University.
Zitieren
APA
Matsuo, K., Abiko, Y., Yamano, S., Toriba, A., Matsusue, K., & Kumagai, Y. (2023). Activation of the Keap1/Nrf2 Pathway as an Adaptive Response to an Electrophilic Metabolite of Morphine. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b22-00543
Vancouver
Matsuo K, Abiko Y, Yamano S, Toriba A, Matsusue K, Kumagai Y. Activation of the Keap1/Nrf2 Pathway as an Adaptive Response to an Electrophilic Metabolite of Morphine. Biological and Pharmaceutical Bulletin. 2023. doi:10.1248/bpb.b22-00543
BibTeX
@article{Matsuo2023,
author = {Matsuo, Kohei and Abiko, Yumi and Yamano, Shigeru and Toriba, Akira and Matsusue, Kimihiko and Kumagai, Yoshito},
title = {Activation of the Keap1/Nrf2 Pathway as an Adaptive Response to an Electrophilic Metabolite of Morphine},
journal = {Biological and Pharmaceutical Bulletin},
year = {2023},
doi = {10.1248/bpb.b22-00543}
}
EUVIMED